The Endevica Team
CEO And Executive Chairman
Russell is an entrepreneur with a full set of product design, business startup and business exit experiences. He is CEO of Battenfeld Technologies, Inc., and the Founder/CEO of PrintNinja; Scarlet Begonias Industrial Development Enterprises; and 511 Capital.
Dr. Daniel L. Marks
Chief Medical Officer and Director
Dr. Marks is an established physician scientist with decades of experience leading basic and clinical research studies including the research program at the Daniel Marks Pediatric Research Lab at Oregon Health & Science University and Doernbecher Children’s Hospital.
Dr. Kenneth Gruber
Founder and Chief Scientific Officer
Dr. Gruber is a former NIH Branch Chief with a decade of experience as an NIH-funded investigator. He is the inventor of six patents protecting the intellectual property used to develop Endevica’s Cachexia treatments. He is a principle investigator on $4 million in NIH/NCI SBIR grants.
Dr. Bobby Sandage
Dr. Sandage is the CEO at Eclises Pharmaceuticals, General Partner at Cultivation Capital Life Sciences Venture Fund, CEO of Coronado Biosciences, VP at Covidien, EVP R&D, CSO, and head of Manufacturing at Indevus
Gene is Treasurer of the Board of Trustees. He specializes in strategic planning and executive consultation. He is Founder of Gerke & Associates and the founder or co-founder of numerous start-ups. He is the Co-Founder and Co-President of Centennial Investors, an Angel Investing Group.
LeAnn Kuhlmann Qi
Chief Commercialization Officer
LeAnn is an entrepreneurial scholar with expertise in digital marketing. She holds an M.B.A. from the University of Missouri’s Crosby MBA Program.